Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,367.60
-7.4 (-0.54%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 77.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
10.46
10.46
10.46
10.46
9.51
9.51
Share Warrants & Outstandings
Total Reserve
2,006.60
1,802.26
1,516.18
1,279.54
1,093.71
760.72
Shareholder's Funds
2,017.06
1,812.72
1,526.65
1,290.00
1,103.22
770.23
Minority Interest
-1.92
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
0.00
6.24
31.25
35.53
Secured Loans
0.00
0.00
0.00
6.24
31.25
35.53
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
42.42
34.02
28.06
23.44
20.97
15.13
Other Long Term Liabilities
1.43
0.63
1.89
0.16
0.31
2.93
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.72
2.82
1.96
2.30
1.87
1.59
Total Non-Current Liabilities
47.58
37.47
31.91
32.13
54.40
55.19
Current Liabilities
Trade Payables
101.91
113.04
94.44
93.80
83.11
71.44
Other Current Liabilities
55.93
65.10
37.59
45.57
40.98
43.58
Short Term Borrowings
0.00
0.38
6.23
25.00
29.34
0.00
Short Term Provisions
11.23
5.54
3.90
27.48
1.75
0.28
Total Current Liabilities
169.08
184.06
142.16
191.84
155.17
115.31
Total Liabilities
2,231.79
2,034.25
1,700.71
1,513.98
1,312.79
940.73
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1,158.89
1,093.13
822.25
791.43
717.48
306.96
Less: Accumulated Depreciation
372.51
300.73
250.20
198.71
145.87
70.55
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
786.37
792.40
572.05
592.72
571.61
236.41
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
78.16
50.13
211.48
172.70
74.16
141.40
Intangible assets under development
1.17
0.53
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
88.58
18.73
2.06
0.12
0.26
0.81
Long Term Loans & Advances
17.94
12.01
12.87
11.84
31.30
15.15
Other Non Current Assets
7.28
22.93
2.75
8.64
1.44
4.96
Total Non-Current Assets
981.68
899.01
804.48
786.28
680.13
401.93
Current Assets Loans & Advances
Current Investments
402.06
316.54
243.70
136.93
73.47
198.11
Inventories
326.36
239.67
207.95
212.31
195.12
111.23
Sundry Debtors
460.20
521.65
349.61
273.76
232.17
183.50
Cash and Bank
13.58
1.18
47.02
43.45
88.93
2.59
Other Current Assets
16.68
27.84
25.34
43.59
13.96
14.51
Short Term Loans and Advances
31.23
28.36
22.60
17.66
29.01
28.86
Total Current Assets
1,250.11
1,135.24
896.23
727.70
632.67
538.79
Net Current Assets (Including Current Investments)
1,081.03
951.18
754.08
535.86
477.50
423.49
Total Current Assets Excluding Current Investments
848.05
818.70
652.53
590.77
559.19
340.69
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,231.79
2,034.25
1,700.71
1,513.98
1,312.79
940.73
Contingent Liabilities
3.76
3.91
14.31
14.31
13.32
3.89
Total Debt
0.00
0.38
6.23
31.24
0.00
35.53
Book Value per share (adjusted)
192.81
173.27
145.93
123.31
105.453636363636
73.6245454545455
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -100.00% vs -93.90% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 126.98% vs -66.67% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 2.61% vs 7.53% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 372.93% vs 809.22% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 10.12% vs 26.67% in Mar 2025

Compare Balance Sheet Results of Concord Biotech
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.46
15.80
-5.34
-33.80%
Share Warrants & Outstandings
Total Reserve
2,006.60
7,077.00
-5,070.40
-71.65%
Shareholder's Funds
2,017.06
7,092.80
-5,075.74
-71.56%
Minority Interest
-1.92
2.80
-4.72
-168.57%
Long-Term Borrowings
0.00
2,971.70
-2,971.70
-100.00%
Secured Loans
0.00
378.00
-378.00
-100.00%
Unsecured Loans
0.00
2,593.70
-2,593.70
-100.00%
Deferred Tax Assets / Liabilities
42.42
-6.40
48.82
762.81%
Other Long Term Liabilities
1.43
2,506.30
-2,504.87
-99.94%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
3.72
159.50
-155.78
-97.67%
Total Non-Current Liabilities
47.58
5,631.10
-5,583.52
-99.16%
Current Liabilities
Trade Payables
101.91
1,234.10
-1,132.19
-91.74%
Other Current Liabilities
55.93
962.70
-906.77
-94.19%
Short Term Borrowings
0.00
247.80
-247.80
-100.00%
Short Term Provisions
11.23
94.30
-83.07
-88.09%
Total Current Liabilities
169.08
2,538.90
-2,369.82
-93.34%
Total Liabilities
2,231.79
15,265.60
-13,033.81
-85.38%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,158.89
9,663.40
-8,504.51
-88.01%
Less: Accumulated Depreciation
372.51
3,130.00
-2,757.49
-88.10%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
786.37
6,533.40
-5,747.03
-87.96%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
78.16
2,961.50
-2,883.34
-97.36%
Intangible assets under development
1.17
1,078.90
-1,077.73
-99.89%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
88.58
61.40
27.18
44.27%
Long Term Loans & Advances
17.94
73.10
-55.16
-75.46%
Other Non Current Assets
7.28
15.80
-8.52
-53.92%
Total Non-Current Assets
981.68
11,156.30
-10,174.62
-91.20%
Current Assets Loans & Advances
Current Investments
402.06
0.00
402.06
0.00%
Inventories
326.36
1,231.50
-905.14
-73.50%
Sundry Debtors
460.20
1,069.60
-609.40
-56.97%
Cash and Bank
13.58
1,267.60
-1,254.02
-98.93%
Other Current Assets
16.68
366.50
-349.82
-95.45%
Short Term Loans and Advances
31.23
174.10
-142.87
-82.06%
Total Current Assets
1,250.11
4,109.30
-2,859.19
-69.58%
Net Current Assets (Including Current Investments)
1,081.03
1,570.40
-489.37
-31.16%
Total Current Assets Excluding Current Investments
848.05
4,109.30
-3,261.25
-79.36%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
2,231.79
15,265.60
-13,033.81
-85.38%
Contingent Liabilities
3.76
419.40
-415.64
-99.10%
Total Debt
0.00
3,219.50
-3,219.50
-100.00%
Book Value per share (adjusted)
192.81
448.91
-256.10
-57.05%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -100.00% vs -93.90% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 126.98% vs -66.67% in Mar 2025

Annual - Fixed Assets
Fixed Assets 864.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.61% vs 7.53% in Mar 2025

Annual - Investments
Investments 88.58 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 372.93% vs 809.22% in Mar 2025

Annual - Current Assets
Current Assets 1,250.11 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.12% vs 26.67% in Mar 2025